Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

NIH 8INDUSTRY 5OTHER 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Mouth Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma in Situ 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × advexin × Clear all
NCT00003450 2021-02-02

Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer

University of Texas Southwestern Medical Center

Phase 1 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00004041 2018-06-27

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01302821 2017-02-23

C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00410865 2011-12-07

Wild Type p53 Adenovirus for Oral Premalignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
Head & Neck

Carcinoma in Situ, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡